186 related articles for article (PubMed ID: 35189272)
1. Methods of in vitro study of galectin-glycomaterial interaction.
Heine V; Dey C; Bojarová P; Křen V; Elling L
Biotechnol Adv; 2022 Sep; 58():107928. PubMed ID: 35189272
[TBL] [Abstract][Full Text] [Related]
2. Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context.
Nielsen MI; Stegmayr J; Grant OC; Yang Z; Nilsson UJ; Boos I; Carlsson MC; Woods RJ; Unverzagt C; Leffler H; Wandall HH
J Biol Chem; 2018 Dec; 293(52):20249-20262. PubMed ID: 30385505
[TBL] [Abstract][Full Text] [Related]
3. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
4. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain.
Nagae M; Nishi N; Murata T; Usui T; Nakamura T; Wakatsuki S; Kato R
Glycobiology; 2009 Feb; 19(2):112-7. PubMed ID: 18977853
[TBL] [Abstract][Full Text] [Related]
6. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways.
Bi S; Earl LA; Jacobs L; Baum LG
J Biol Chem; 2008 May; 283(18):12248-58. PubMed ID: 18258591
[TBL] [Abstract][Full Text] [Related]
7. Chemokines modulate glycan binding and the immunoregulatory activity of galectins.
Sanjurjo L; Schulkens IA; Touarin P; Heusschen R; Aanhane E; Castricum KCM; De Gruijl TD; Nilsson UJ; Leffler H; Griffioen AW; Elantak L; Koenen RR; Thijssen VLJL
Commun Biol; 2021 Dec; 4(1):1415. PubMed ID: 34931005
[TBL] [Abstract][Full Text] [Related]
8. Analysis of selected blood and immune cell responses to carbohydrate-dependent surface binding of proto- and chimera-type galectins.
Timoshenko AV; Gorudko IV; Maslakova OV; André S; Kuwabara I; Liu FT; Kaltner H; Gabius HJ
Mol Cell Biochem; 2003 Aug; 250(1-2):139-49. PubMed ID: 12962152
[TBL] [Abstract][Full Text] [Related]
9. Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival.
Elola MT; Wolfenstein-Todel C; Troncoso MF; Vasta GR; Rabinovich GA
Cell Mol Life Sci; 2007 Jul; 64(13):1679-700. PubMed ID: 17497244
[TBL] [Abstract][Full Text] [Related]
10. Targeting galectin-driven regulatory circuits in cancer and fibrosis.
Mariño KV; Cagnoni AJ; Croci DO; Rabinovich GA
Nat Rev Drug Discov; 2023 Apr; 22(4):295-316. PubMed ID: 36759557
[TBL] [Abstract][Full Text] [Related]
11. Galectin-7 in Epithelial Homeostasis and Carcinomas.
Advedissian T; Deshayes F; Viguier M
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257082
[TBL] [Abstract][Full Text] [Related]
12. Advanced high-affinity glycoconjugate ligands of galectins.
Hovorková M; Červený J; Bumba L; Pelantová H; Cvačka J; Křen V; Renaudet O; Goyard D; Bojarová P
Bioorg Chem; 2023 Feb; 131():106279. PubMed ID: 36446202
[TBL] [Abstract][Full Text] [Related]
13. Galectin-Carbohydrate Interactions in Biomedicine and Biotechnology.
Laaf D; Bojarová P; Elling L; Křen V
Trends Biotechnol; 2019 Apr; 37(4):402-415. PubMed ID: 30413271
[TBL] [Abstract][Full Text] [Related]
14. Synthetic Mucin-Like Glycopeptides as Versatile Tools to Measure Effects of Glycan Structure/Density/Position on the Interaction with Adhesion/Growth-Regulatory Galectins in Arrays.
Artigas G; Hinou H; Garcia-Martin F; Gabius HJ; Nishimura SI
Chem Asian J; 2017 Jan; 12(1):159-167. PubMed ID: 27873468
[TBL] [Abstract][Full Text] [Related]
15. Oligosaccharide Ligands of Galectin-4 and Its Subunits: Multivalency Scores Highly.
Slámová K; Červený J; Mészáros Z; Friede T; Vrbata D; Křen V; Bojarová P
Molecules; 2023 May; 28(10):. PubMed ID: 37241779
[TBL] [Abstract][Full Text] [Related]
16. An integrated computational analysis of the structure, dynamics, and ligand binding interactions of the human galectin network.
Guardia CM; Gauto DF; Di Lella S; Rabinovich GA; Martí MA; Estrin DA
J Chem Inf Model; 2011 Aug; 51(8):1918-30. PubMed ID: 21702482
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.
Laderach DJ; Compagno D; Toscano MA; Croci DO; Dergan-Dylon S; Salatino M; Rabinovich GA
IUBMB Life; 2010 Jan; 62(1):1-13. PubMed ID: 20014236
[TBL] [Abstract][Full Text] [Related]
18. Binding and cross-linking properties of galectins.
Fred Brewer C
Biochim Biophys Acta; 2002 Sep; 1572(2-3):255-62. PubMed ID: 12223273
[TBL] [Abstract][Full Text] [Related]
19. Engineering galectin-glycan interactions for immunotherapy and immunomodulation.
Farhadi SA; Hudalla GA
Exp Biol Med (Maywood); 2016 May; 241(10):1074-83. PubMed ID: 27229902
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions.
Sörme P; Kahl-Knutsson B; Huflejt M; Nilsson UJ; Leffler H
Anal Biochem; 2004 Nov; 334(1):36-47. PubMed ID: 15464951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
